Research Article
Central Systolic Hypertension in Patients with Well-Controlled Hypertension
Table 5
Antihypertensive and hypolipidemic treatment.
| Number of drugs per patient (, mean ± SD) | 2.6 ± 1.2 |
| Percentage distribution of antihypertensive drugs used |
| ACE inhibitors, ACEI (%) | 55 | Calcium channel blockers (dihydropyridines), CCB (%) | 55 | Diuretics, D (%) | 54 | Beta-blockers, BB (%) | 52 | Angiotensin II receptor blockers (ARBs) (%) | 21 | Centrally acting antihypertensives (%) | 12 | Calcium channel blocker nondihydropyridine, verapamil (%) | 9 | Alpha-adrenoreceptor blocking drugs, AB (%) | 6 | Urapidil (%) | 6 | Statin therapy (%) | 53 | Fibrate therapy (%) | 11 |
|
|